Cano ALE,  Díaz AA, Cacho DB, Durán PA

Language: Spanish
References: 9
Page: 106-110
PDF size: 129.59 Kb.

ABSTRACT

Tumoral epilepsy is a neurodegenerative disorder that represents 6% of all currently diagnosed epilepsies. This disorder is frequently described in a supratentorial location in the supragranular layer of the peritumoral neocortex. The proepileptogenic molecules involved in the pathophysiology are glutamate, gamma aminobutyric acid (GABA), potassium, fibrinogen and albumin, whose alterations in the central nervous system (CNS) are explained by two theories: epileptocentric and the tumorocentric theory. The importance of tumoral epilepsy relies in being considered a sign of presentation of specific tumoral lines (ganglioglioma, oligodendroglioma) and acting as an objective marker of tumoral progression. The electroencephalogram and the nuclear magnetic resonance are the two essential diagnostic tools. The management of tumoral epilepsy is based on pharmacological and surgical treatment, taking into consideration the tumor excision, the timing of the seizures, response to treatment, the patient’s prognosis, directly impacting on the morbidity and mortality of patients with CNS tumors.

REFERENCES

1. Lhatoo SD, Moghimi N, Schuele S. Tumor-related epilepsy and epilepsy surgery. Epilepsia. 2013; 54: 1-4.

2. Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013; 54: 12-17.

3. Pallud J, Capelle L, Huberfeld G. Tumoral epileptogenicity: how does it happen? Epilepsia. 2013; 54: 30-34.

4. Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014; 19: 751-759.

5. Rudà R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol. 2012; 4: 55-64.

6. Perucca E. Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia. 2013; 54: 97-104.

7. Koekkoek JA, Kerkhof M, Dirven L, Heimans JJ, Reijneveld JC, Taphoorn MJ. Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review. Neuro Oncol. 2015; 17: 924-934.

8. Cacho-Díaz B, San-Juan D, Salmeron K, Boyzo C, Lorenzana-Mendoza N. Choice of antiepileptic drugs affects the outcome in cancer patients with seizures. Clin Transl Oncol. 2018; 20 (12): 1571-1576.

9. Kerkhof M, Dielemans JC, van Breemen MS, Zwinkles H, Walchenbach R, Taphoorn MJ, Vecht CJ. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Acta Neurol Scand. 2016; 133 (1): 4-16.